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Protozoan infection is the cause of diseases of high mor-
bidity and mortality. Most are non-self-limiting chronic
infections and neglected diseases; emergent antimicrobial-
resistant strains pose a substantial problem; formany of them
treatment either is highly toxic or has limited effectiveness.
Vaccine development is still a formidable task and there is
no licensed vaccine for human protozoan infection. The key
to the control of protozoan infection is the understanding of
the host immune response to protozoan parasites, which will
guide the development of effective vaccines and immunother-
apeutic agents. In this special issue, there are important
studies on the immunology of T. cruzi infection, tegumentary
and visceral leishmaniasis, malaria, and toxoplasmosis, both
in patients and in animal models, which promote the under-
standing of immunopathological/immunoprotective param-
eters in these diseases.
The reviews by J. M. A´lvarez and colleagues and by E.
Cunha-Neto and C. Chevillard cover fundamental findings,
mechanisms, andquestions concerning the immune response
and pathology of mouse and human disease. In this line,
L. G. Nogueira and colleagues characterize the myocardial
expression of transcriptional factors involved in effector
CD4+ T cell differentiation and the characteristic cytokines
produced by the distinct lymphocyte subsets and demon-
strate a profound predominance of local Th1 response. L.
C. J. Abel and coworkers characterized the proinflammatory
effects of glicophosphatidyl inositol-anchored T. cruzimucin
(GPI-mucins) on human immune cells. It was observed that
IL-12 production by GPI-mucins was dependent on IFN-
𝛾 and CD40-CD40L interactions. F. C. Dias and colleagues
investigated the HLA-G expression in tissues and HLA-G
147 3󸀠 UTR polymorphic site typing in patients presenting
Chagas disease and the role of themouse functional homolog
in T. cruzi infection. F. Vorraro and colleagues studied the
susceptibility to T. cruzi of mouse strains previously selected
based on inflammatory and antibody responses to complex
antigens. Q. Miao and M. Ndao review the potential impact
of T. cruzi infection on the status of host lipid metabolism.
The role of lipid mediators in T. cruzi infection is explored
in two research articles. A. M. C. Canavaci and colleagues
revisit the pathological role of 5-lipoxygenase in the acute
infection ofmice andA.D.Malvezi and coworkers investigate
the role of cyclooxygenase and lipoxins in macrophage
invasion by T. cruzi. In mouse models of chronic myocardial
disease by T. cruzi, I. R. Pereira and colleagues show that
treatment with infliximab, an anti-human TNF monoclonal
antibody, reduced the frequency of mice with arrhythmias
and cardiac fibrosis, whileM. B. de Cuba and coworkers show
the beneficial effect of cholinergic stimulation in reducing
inflammation and fibrosis in the heart. Importantly, A. F.
Arau´jo and coworkers demonstrate the beneficial effects of
prophylactic vaccination using T. cruzi genes against acute
and chronic pathologies caused by myotropic strains of the
parasite. W. H. K. Cabrera and colleagues have characterized
mouse lines selected for maximal (AIRmax) or minimal
(AIRmin) acute inflammatory reaction and for high (HIII)
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or low (LIII) antibody (Ab) responses to complex antigens.
Resistance to T. cruzi infection was found in female and in
high responder lines AIRmax andHIII. It was correlated with
enhanced production of IFN-𝛾 and nitric oxide production
by peritoneal and lymph node cells, in HIII males and
females. Moreover, an Ab production QTL marker mapping
to mouse chromosome 1 significantly cosegregated with
survival after acute T. cruzi infection.
In the Leishmania field, M. F. Lopes and colleagues
here review the interface between Leishmania and phago-
cytes, cells that are both targets and effector of the anti-
Leishmania immune response. The study by E. Svensjo¨ and
colleagues suggests that a serine peptidase (ISP-2) from L.
major regulates macrophage phagocytosis by inhibiting the
pericellular release of proinflammatory kinins from surface
bound kininogens. C. M. V. Vendrame and coworkers have
shown that insulin-like growth factor- (IGF-) I decreased
nitric oxide production but increased arginase expression
and activity, which lead to increased Leishmania parasitism.
However, IGF-I did not result in altered cytokine levels.
Moreover, stimulation with IGF-I induced phosphatidylser-
ine exposure on amastigotes led to increased arginase activity
in macrophages, and this process was not blocked by anti-
TGF-𝛽 antibodies. M. D. T. Carvalho and colleagues inves-
tigated risk markers of L. infantum visceral leishmaniasis
and found that lipoprotein and triglyceride levels are risk
factors for development of visceral leishmaniasis. They also
found that genetic polymorphisms at the Lpl and Ppar𝛾
were associated with differential levels of lipoproteins and
thus related to the disease outcome. I. Naouar and cowork-
ers investigated granzyme-positive CD4+ T cells activated
by L. major antigens, in Leishmania-healed subjects. They
found that even CD4+CD25+CD127dim/− Tregs expressed
granzyme after exposure to Leishmania antigens.
A number of manuscripts published in this issue provide
important new knowledge in the important field ofmalaria. A
review from H. Zheng and colleagues highlighted important
aspects of preerythrocytic stages biology and the immune
evasion strategies of malaria parasites. The unraveling of
these escape mechanisms may aid the development of a vac-
cine against malaria. In this same direction, the manuscript
by the group of J. Huang and colleagues generated a new
mouse model to study the immunity to these preerythrocytic
stages.This newmodel employed transgenicMHC-IKdmice.
The results of their studies indicate that protective antimalaria
immunity induced by radiation-attenuated sporozoites of
Plasmodium yoelii in MHC-I-Kd-Tg mice is mediated by CS
protein-specific, Kd-restricted CD8+ T cells. E. S. Fernandes
and colleagues studied the effect of TRPV1 antagonism
by capsazepine during mouse infection with Plasmodium
berghei ANKA. Their result indicated that there was a mod-
ulation of the innate immune response in mice infected but
it did not affect parasitemia. Two other studies dealt with
malaria pathogenesis. L. S. Ortolan and coworkers described
new predictive criteria to study the pathogenesis of malaria-2
associated ali/ards inmice.Thismethod for accurately identi-
fying mice suffering from ALI/ARDS before death will allow
the use of this model to study the pathogenesis of this disease.
Finally, J. C. Sa´nchez-Arcila and colleagues evaluatedwhether
intestinal parasites coinfection would alter plasma cytokines
profile elicited in acutemalaria in subjects from endemic area
of Brazil. They concluded that the infection with intestinal
parasites (mainly protozoan) does not significantly modify
the pattern of cytokine production in individuals infected
with P. falciparum and P. vivax.
Finally, A. S. Machado and colleagues investigated the
immunopathogenesis of toxoplasmosis in parturients and
nonpregnant women.Theymeasured the synthesis ofTh1 and
Th2 cytokines by mononuclear cells after culture with live T.
gondii and identified Th17 (CD4+) and Tc17 (CD8+) cells in
toxoplasma-seronegative and toxoplasma-seropositive par-
turient and nonpregnant women. They observed a lower
level of IL-17-expressing CD4+ and CD8+ T lymphocytes
in cultures of cells from seronegative and seropositive par-
turient and nonpregnant women that were stimulated with
tachyzoites. It has been shown that the cytokine pattern and
IL-17-expressing CD4+ and CD8+ T lymphocytes may have
important roles in the inflammatory response to T. gondii,
thus contributing to the maintenance of pregnancy and
control of parasite invasion and replication. A. S. Machado
and coworkers studied immunological and hematological
biomarkers of ocular congenital toxoplasmosis in infants,
finding differential immune parameter networks in each
clinical group (active and cicatricial ocular toxoplasmosis).
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